about
Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitisClobazam monotherapy for partial-onset or generalized-onset seizuresAntiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitisA readability assessment of online Parkinson's disease informationThe evaluation of a tailored intervention to improve the management of suspected viral encephalitis: protocol for a cluster randomised controlled trialThe development of an intervention to promote adherence to national guidelines for suspected viral encephalitis.Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines.Suboptimal management of central nervous system infections in children: a multi-centre retrospective studyInflammatory osteoarthritis which was precipitated by Arimidex and resolved with tamoxifen.Controversies in HIV-associated neurocognitive disordersHerpes simplex virus encephalitis in pregnancy - a case report and review of reported patients in the literature.Characteristic Cytokine and Chemokine Profiles in Encephalitis of Infectious, Immune-Mediated, and Unknown Aetiology.Hyperosmolar non-ketotic hyperglycaemia: an important and reversible cause of acute bilateral ballismus.A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals.Seizures and encephalitis: clinical features, management, and potential pathophysiologic mechanisms.Infective Causes of Epilepsy.Management of suspected herpes simplex virus encephalitis in adults in a U.K. teaching hospital.The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults.Kikuchi-Fujimoto disease as a rare cause of fever of unknown origin in a septuagenarian.When should we test for voltage-gated potassium channel complex antibodies? A retrospective case control study.CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSFManaging patients with encephalitis.Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study.Diffuse primary leptomeningeal melanocytosis in a patient receiving a novel cancer cell vaccine for prostate cancerTest them all; an easily diagnosed and readily treatable cause of dementia with life-threatening consequences if missed.Corrigendum to "The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent Adults" [J Infect 72 (2016) 405-438].Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - a pilot study.Arteriovenous malformation: a rare cause of trigeminal neuralgia identified by magnetic resonance imaging with constructive interference in steady state sequences.Brain microvascular endothelial-astrocyte cell responses following Japanese encephalitis virus infection in an in vitro human blood-brain barrier model.'Twas the night before Grand Round ….Act now against new NHS competition regulationsEffect of delayed lumbar punctures on the diagnosis of acute bacterial meningitis in adultsIncidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort studyA pragmatic cluster randomised controlled trial of a tailored intervention to improve the initial management of suspected encephalitisMultiple cranial neuropathies: one diagnostic difficultyHow to do it: how to get the most out of cerebrospinal fluid cytologyAn appreciation of the science and philanthropy of Sir Oliver Scott, founder of the Gray Cancer InstituteManaging acute central nervous system infections in the UK adult intensive care unit in the wake of UK encephalitis guidelinesParasitic encephalitis in immunocompetent individuals - Authors' replyAntiepileptic drugs for seizure control in people with neurocysticercosis
P50
Q24193125-CB4E756D-9603-4B95-95E0-E0E5A432DAE7Q24193187-8009DAB6-8953-4281-A2E7-A5C19911D9C1Q26471960-E3946A3E-1A98-43CC-8A3F-7D737ECBBE68Q28299937-5D8212F0-285B-4B4D-8384-C4C99C0DF0DEQ30619499-25CF5541-A6D0-47DB-A7B4-929284E5D658Q30631985-C37C92AE-EB75-4201-989E-CFD5994FF7FCQ34236244-1AD04534-494C-401B-8D14-419188EFA1C4Q34408643-0CA63EFE-E1B1-413E-A901-6FA569A2DF92Q34536015-0F48D8F7-0F3C-4F35-AE8F-4DE9F0FEAB52Q35037015-A9C02F04-732B-48C9-ABBC-4095F9E8F94DQ35258264-BAB90546-A34C-4373-9F4E-13012CB8B40BQ35903495-1350C7B3-4B9A-400C-A77D-E1B6A7D3AE0EQ35975932-0CFBDF0B-E539-49F4-A599-C9E4912676BAQ37416972-E43A2987-E2F7-477F-A879-B17EA7D8A024Q38040444-BFB66F0A-A8CA-479E-AA70-0AF792331708Q38523463-277B946D-474A-4FF0-840D-B7E487C80040Q38901056-13FA27CB-491A-48F0-BC50-E5F8D5BE4711Q39233858-7A8EF984-4A26-4BF8-BABD-E265113DD5F3Q40424255-9AD81B56-EC7E-4DBE-92D4-6F6DA23ACE00Q40596206-9C68002B-CF67-47C2-A513-C5F74775C35CQ40692788-F02A45E9-A417-4158-9907-2B286764432CQ40915583-9CA2D547-909D-43EB-9DCA-9FBE7787753BQ42248235-EACE7F03-391D-412B-A57F-F55FD4CCE9F4Q42645664-7FC18173-65E6-410F-A5D8-92D9CE306257Q42865590-1DDD6183-E8C3-4CBC-B9C1-0C717D5B61F5Q43174637-47BF935F-B60B-46DD-BCEF-413D7D3AAE59Q46220780-CA53466E-6839-4C11-AE9F-4266718D386FQ48929963-B83A10BA-DBF8-41BA-91B9-67F6A00493F3Q52690986-12C49990-124E-4D69-9FC1-956DCF6AC9F5Q53248878-98F02622-85BA-498C-9C76-247F8D8C32B0Q56331237-B2ECB542-F5C7-4AE6-AA09-E1DC4A9B7F95Q56795495-9EC851EE-8C65-4788-A944-D3739529CE9CQ58777894-F5B8A88E-1C0A-4FA4-A200-1E822A50AB03Q60046327-E660AE44-A0BA-4001-894C-D09BEE681C96Q84283658-B7CCD7C3-A182-44D2-8109-0E7D141F2130Q84744311-88378A09-25D4-4676-A440-ADB1CA3EF5D3Q89114846-194B7C6E-5185-4FF1-8B44-591CDCA30A46Q89144609-D480816A-EFD2-48AA-8AA4-7030F2ADE8D8Q90129900-9D1CFDF6-AB2F-4F39-96FF-D4787F14DB67Q90686696-5B8965E8-5C66-4C49-A290-A8809AC91D76
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Benedict D Michael
@ast
Benedict D Michael
@en
Benedict D Michael
@es
Benedict D Michael
@nl
Benedict D Michael
@sl
type
label
Benedict D Michael
@ast
Benedict D Michael
@en
Benedict D Michael
@es
Benedict D Michael
@nl
Benedict D Michael
@sl
prefLabel
Benedict D Michael
@ast
Benedict D Michael
@en
Benedict D Michael
@es
Benedict D Michael
@nl
Benedict D Michael
@sl
P106
P21
P31
P496
0000-0002-8693-8926